Edwards Lifesciences Corporation (EW)

NYSE: EW · Real-Time Price · USD

89.28

+3.54 (4.13%)

At close: Sep 16, 2026, 4:00 PM EDT

89.27

-0.01 (-0.01%)

After-hours: Sep 16, 2026, 7:55 PM EDT

Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	51,461	49,471	43,663	46,246	46,128	80,883
Market Cap Growth	13.00%	13.30%	-5.58%	0.25%	-42.97%	42.25%
Enterprise Value	47,884	46,323	39,982	45,142	45,077	79,772
Last Close Price	89.28	85.25	74.03	76.25	74.61	129.55

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	53.27	46.08	10.46	32.98	30.31	53.81
Forward PE	28.43	30.93	31.19	28.41	30.35	52.98
PS Ratio	7.90	8.15	8.03	9.23	10.33	15.46
PB Ratio	4.85	4.79	4.34	6.88	7.94	13.86
P/TBV Ratio	7.06	6.65	6.20	9.06	10.59	18.62
P/FCF Ratio	35.90	37.06	150.61	71.94	47.38	57.51
P/OCF Ratio	29.91	31.01	80.51	51.63	37.87	46.70
PEG Ratio	2.34	3.24	3.69	2.77	2.95	3.38

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	7.35	7.63	7.35	9.01	10.10	15.25
EV/EBITDA Ratio	23.98	25.81	24.62	28.05	26.81	46.34
EV/EBIT Ratio	26.15	28.28	27.00	30.35	29.24	50.28
EV/FCF Ratio	33.40	34.70	137.92	70.23	46.30	56.73

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.35	0.39	0.42	0.42	0.40	0.39
Debt / FCF Ratio	0.49	0.53	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.33	-0.34	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.79	-1.97	-2.02	-0.59	-0.31	-0.45
Net Debt / FCF Ratio	-2.49	-2.64	-11.32	-1.47	-0.54	-0.55
Asset Turnover	0.48	0.45	0.49	0.57	0.53	0.67
Inventory Turnover	1.27	1.21	1.12	1.10	0.90	1.63
Quick Ratio	3.45	2.83	3.13	2.06	1.87	2.07
Current Ratio	4.52	3.72	4.18	3.38	3.03	3.08
Return on Equity (ROE)	9.18%	10.35%	16.64%	19.48%	22.74%	28.88%
Return on Assets (ROA)	8.37%	7.65%	8.26%	10.53%	11.47%	12.60%
Return on Invested Capital (ROIC)	17.39%	19.98%	21.26%	23.92%	25.98%	31.39%
Return on Capital Employed (ROCE)	14.80%	13.80%	12.80%	18.20%	21.20%	21.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	1.95%	2.17%	9.56%	3.03%	3.30%	1.86%
FCF Yield	2.79%	2.70%	0.66%	1.39%	2.11%	1.74%
Buyback Yield / Dilution	1.64%	2.25%	1.66%	2.37%	1.11%	0.11%

SEC Filings: 10-K · 10-Q